Splenic infarction and bevacizumab

David Malka, Marc Van Den Eynde, Valérie Boige, Clarisse Dromain, Michel Ducreux

Résultats de recherche: Contribution à un journal › !!Comment/debate

8 Citations (Scopus)

Accès au document

@article{b23889986e964c3b8fe13aa9ca261e5a,

title = "Splenic infarction and bevacizumab",

author = "David Malka and {Van Den Eynde}, Marc and Val{\'e}rie Boige and Clarisse Dromain and Michel Ducreux",

year = "2006",

month = dec,

day = "1",

doi = "10.1016/S1470-2045(06)70980-9",

language = "English",

volume = "7",

pages = "1038",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "12",

}

TY - JOUR

T1 - Splenic infarction and bevacizumab

AU - Malka, David

AU - Van Den Eynde, Marc

AU - Boige, Valérie

AU - Dromain, Clarisse

AU - Ducreux, Michel

PY - 2006/12/1

Y1 - 2006/12/1

UR - http://www.scopus.com/inward/record.url?scp=33751316745&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(06)70980-9

DO - 10.1016/S1470-2045(06)70980-9

M3 - Comment/debate

C2 - 17138227

AN - SCOPUS:33751316745

SN - 1470-2045

VL - 7

SP - 1038

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 12

ER -